InvestSMART

Blackmores Limited (ASX: BKL) - Announcements

DELISTED - Current share price for BKL : $94.730

ASX company news and announcements for Blackmores Limited (BKL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Blackmores Limited (BKL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Blackmores Limited (BKL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Blackmores Limited (BKL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Change of Director's Interest Notice 12 May 2021 8:24AM $66.180 $94.730 risen by 43.14%
- Macquarie Conference Presentation 5 May 2021 2:03PM $70.550 $94.730 risen by 34.27%
- Initial Director's Interest Notice 30 Apr 2021 6:21PM $71.640 $94.730 risen by 32.23%
- Initial Director's Interest Notice 30 Apr 2021 6:16PM $71.640 $94.730 risen by 32.23%
- BKL Non-Executive Director Appointments 28 Apr 2021 10:54AM $71.270 $94.730 risen by 32.92%
- BKL Shareholder Briefing 22 Apr 2021 9:41AM $84.240 $94.730 risen by 12.45%
- Appendix 2A 12 Apr 2021 6:56PM $80.590 $94.730 risen by 17.55%
- Appendix 2A 12 Apr 2021 6:38PM $80.590 $94.730 risen by 17.55%
- Update - Dividend/Distribution - BKL 1 Apr 2021 11:16AM $79.050 $94.730 risen by 19.84%
- Change in substantial holding 22 Mar 2021 4:40PM $84.720 $94.730 risen by 11.82%
- Change in substantial holding 10 Mar 2021 8:22AM $81.580 $94.730 risen by 16.12%
- BKL Half Year Investor Presentation 24 Feb 2021 9:04AM $74.100 $94.730 risen by 27.84%
- BKL Half Year Results Announcement 24 Feb 2021 9:00AM $74.100 $94.730 risen by 27.84%
- Dividend/Distribution - BKL 24 Feb 2021 8:55AM $74.100 $94.730 risen by 27.84%
- Half Year Accounts 24 Feb 2021 8:54AM $74.100 $94.730 risen by 27.84%
- Resignation of Joint Company Secretary 4 Jan 2021 5:22PM $75.110 $94.730 risen by 26.12%
- Becoming a substantial holder 22 Dec 2020 5:05PM $73.700 $94.730 risen by 28.53%
- Appendix 3G 17 Dec 2020 5:25PM $74.910 $94.730 risen by 26.46%
- Change of Director's Interest Notice 17 Dec 2020 5:21PM $74.910 $94.730 risen by 26.46%
- Completion of Global Therapeutics Divestment 1 Dec 2020 8:25PM $79.190 $94.730 risen by 19.62%
- Initial Director's Interest Notice 29 Oct 2020 6:39PM $71.520 $94.730 risen by 32.45%
- Final Director's Interest Notice 29 Oct 2020 6:28PM $71.520 $94.730 risen by 32.45%
- Final Director's Interest Notice 29 Oct 2020 5:58PM $71.520 $94.730 risen by 32.45%
- Results of Meeting 27 Oct 2020 2:35PM $64.510 $94.730 risen by 46.85%
- MCP: Global Therapeutics Acquisition & Equity Raise 27 Oct 2020 10:32AM $67.420 $94.730 risen by 40.51%

126 - 150 of 442 results

Page 6 of 18

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.